These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34092513)

  • 1. Is there an association between prostate-specific antigen and androgen levels in 46, XX patients with congenital adrenal hyperplasia?
    de Almeida RB; Apóstolos RAC; Oliveira LMB; Toralles MBP; Lago RMRS; Faria JAD; Arruti RA; Rodrigues MLB; Amorim T; Dos Santos HMGP; de Sousa LA; Barroso U
    J Pediatr Urol; 2021 Aug; 17(4):481.e1-481.e7. PubMed ID: 34092513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgens concentrations and second-to fourth-digit ratio (2D:4D) in girls with congenital adrenal hyperplasia (21-hydroxylase deficiency).
    Oswiecimska JM; Ksiazek A; Sygulla K; Pys-Spychala M; Roczniak GR; Roczniak W; Stojewska M; Ziora K
    Neuro Endocrinol Lett; 2012; 33(8):787-91. PubMed ID: 23391972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid 17-Hydroxyprogesterone in Hair Is a Potential Long-Term Biomarker of Androgen Control in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.
    Auer MK; Krumbholz A; Bidlingmaier M; Thieme D; Reisch N
    Neuroendocrinology; 2020; 110(11-12):938-949. PubMed ID: 31711056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 46,XX males with congenital adrenal hyperplasia: a clinical and biochemical description.
    Adriaansen BPH; Utari A; Westra D; Juniarto AZ; Ariani MD; Ediati A; Schröder MAM; Span PN; Sweep FCGJ; Drop SLS; Faradz SMH; van Herwaarden AE; Claahsen-van der Grinten HL
    Front Endocrinol (Lausanne); 2024; 15():1410122. PubMed ID: 39175568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche.
    Armengaud JB; Charkaluk ML; Trivin C; Tardy V; Bréart G; Brauner R; Chalumeau M
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2835-40. PubMed ID: 19454583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characterization of a cohort of pediatric patients with Congenital Adrenal Hyperplasia].
    Suárez DV; Matorel E; Niño-Serna L; Toro-Ramos M
    Andes Pediatr; 2022 Aug; 93(4):511-519. PubMed ID: 37906849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17-hydroxyprogesterone, androstenedione, and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia.
    von Schnakenburg K; Bidlingmaier F; Knorr D
    Eur J Pediatr; 1980 May; 133(3):259-67. PubMed ID: 7389739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Search of prostatic tissue in 46,XX congenital adrenal hyperplasia].
    Paulino Mda C; Steinmetz L; Menezes Filho HC; Kuperman H; Della Manna T; Vieira JG; Blasbalg R; Baroni R; Setian N; Damiani D
    Arq Bras Endocrinol Metabol; 2009 Aug; 53(6):716-20. PubMed ID: 19893913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between androstenedione and 17-hydroxyprogesterone levels in the saliva and plasma of patients with congenital adrenal hyperplasia.
    Juniarto AZ; Goossens K; Setyawati BA; Drop SL; de Jong FH; Faradz SM
    Singapore Med J; 2011 Nov; 52(11):810-3. PubMed ID: 22173250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crinecerfont, a CRF1 Receptor Antagonist, Lowers Adrenal Androgens in Adolescents With Congenital Adrenal Hyperplasia.
    Newfield RS; Sarafoglou K; Fechner PY; Nokoff NJ; Auchus RJ; Vogiatzi MG; Jeha GS; Giri N; Roberts E; Sturgeon J; Chan JL; Farber RH
    J Clin Endocrinol Metab; 2023 Oct; 108(11):2871-2878. PubMed ID: 37216921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital Adrenal Hyperplasia in Children: A Pilot Study of Steroid Hormones Expressed as Sex- and Age-Related Standard Deviation Scores.
    Clausen CS; Ljubicic ML; Main KM; Andersson AM; Petersen JH; Frederiksen H; Duno M; Johannsen TH; Juul A
    Horm Res Paediatr; 2020; 93(4):226-238. PubMed ID: 33017824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scalp hair 17-hydroxyprogesterone and androstenedione as a long-term therapy monitoring tool in congenital adrenal hyperplasia.
    Noppe G; de Rijke YB; Koper JW; van Rossum EF; van den Akker EL
    Clin Endocrinol (Oxf); 2016 Oct; 85(4):522-7. PubMed ID: 27061431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 4-hour Profile of 17-hydroxyprogesterone in Salt-wasting Congenital Adrenal Hyperplasia: Is the Serial Monitoring Strategy Worth the Effort?
    Besci Ö; Erbaş İM; Küme T; Acinikli KY; Abacı A; Böber E; Demir K
    J Clin Res Pediatr Endocrinol; 2022 Jun; 14(2):145-152. PubMed ID: 34866371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of nonclassical congenital adrenal hyperplasia in patients with precocious adrenarche.
    Morris AH; Reiter EO; Geffner ME; Lippe BM; Itami RM; Mayes DM
    J Clin Endocrinol Metab; 1989 Oct; 69(4):709-15. PubMed ID: 2550505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender dysphoria and XX congenital adrenal hyperplasia: how frequent is it? Is male-sex rearing a good idea?
    de Jesus LE; Costa EC; Dekermacher S
    J Pediatr Surg; 2019 Nov; 54(11):2421-2427. PubMed ID: 30905417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diurnal salivary androstenedione and 17-hydroxyprogesterone levels in healthy volunteers for monitoring treatment efficacy of patients with congenital adrenal hyperplasia.
    Adriaansen BPH; Kamphuis JS; Schröder MAM; Olthaar AJ; Bock C; Brandt A; Stikkelbroeck NMML; Lentjes EGWM; Span PN; Sweep FCGJ; Claahsen-van der Grinten HL; van Herwaarden AE
    Clin Endocrinol (Oxf); 2022 Jul; 97(1):36-42. PubMed ID: 35150157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17-Hydroxyprogesterone in children, adolescents and adults.
    Honour JW
    Ann Clin Biochem; 2014 Jul; 51(Pt 4):424-40. PubMed ID: 24711560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of serum steroids in monitoring therapy of congenital adrenal hyperplasia].
    Xiao HW; Ma HM; Su Z; Du ML; Li YH; Chen HS; Chen QL
    Zhonghua Er Ke Za Zhi; 2012 Apr; 50(4):301-7. PubMed ID: 22801236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring congenital adrenal hyperplasia using blood spot 17-hydroxyprogesterone assay.
    Santos CM; Abad LR; Cua SC; Domingo CF
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():174-8. PubMed ID: 15906729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of urinary 17 alpha-hydroxyprogesterone excretion using ELISA--evaluation of normal subjects and patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
    Shibata Y
    Nihon Naibunpi Gakkai Zasshi; 1991 Aug; 67(8):819-39. PubMed ID: 1813324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.